Table 3 Asthma control and indicators of symptoms and exacerbations by treatment level

From: Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey

 

Reliever only (n=1,419)

Single-drug preventer inhaler (n=1,923)

Combination preventer inhaler (n=754)

Combination preventer inhaler plus oral pill (n=234)

Control and indicators of symptoms

GINA-defined control level

Controlled

408 (28.8)

465 (24.2)

165 (21.9)

40 (17.1)

Partially controlled

594 (41.9)

700 (36.4)

278 (36.9)

79 (33.8)

Uncontrolled

417 (29.4)

758 (39.4)

311 (41.2)

115 (49.1)

 Normal activities affected by symptomsa

None

732 (51.6)

986 (51.3)

387 (51.3)

92 (39.3)

1 day

687 (48.4)

937 (48.7)

367 (48.7)

142 (60.7)

3 days

187 (13.2)

318 (16.5)

160 (21.2)

67 (28.6)

 Days with symptomsa

None

370 (26.1)

417 (21.7)

164 (21.8)

37 (15.8)

1 day

1,049 (73.9)

1,506 (78.3)

590 (78.2)

197 (84.2)

3 days

389 (27.4)

724 (37.6)

340 (45.1)

115 (49.1)

 Night-time awakeninga

None

801 (56.4)

1,045 (54.3)

392 (52.0)

114 (48.7)

1 day

618 (43.6)

878 (45.7)

362 (48.0)

120 (51.3)

 Reliever inhaler usea

Not used

540 (38.1)

559 (29.1)

208 (27.6)

53 (22.6)

1 times

871 (61.4)

1,297 (67.4)

501 (66.4)

172 (73.5)

3 times

430 (30.3)

786 (40.9)

326 (43.2)

112 (47.9)

10 times

38 (2.7)

139 (7.2)

64 (8.5)

23 (9.8)

Acute exacerbations

 Antibiotic use for an asthma-associated conditionb

0

698 (49.2)

860 (44.7)

334 (44.3)

69 (29.5)

1 course

721 (50.8)

1,063 (55.3)

420 (55.7)

165 (70.5)

 Oral steroid use for worsening asthmab

0

1,049 (73.9)

1,362 (70.8)

455 (60.3)

86 (36.8)

1 course

370 (26.1)

561 (29.2)

299 (39.7)

148 (63.2)

 Emergency department visit due to asthmab

0

1,243 (87.6)

1,650 (85.8)

614 (81.4)

164 (70.1)

1 visit

176 (12.4)

273 (14.2)

140 (18.6)

70 (29.9)

 Overnight hospitalisation due to asthmab

0

1,369 (96.5)

1,843 (95.8)

696 (92.3)

194 (82.9)

1 stay

50 (3.5)

80 (4.2)

58 (7.7)

40 (17.1)

  1. Data are shown as n (%) of patients. Only patients with an identifiable treatment were included.
  2. Abbreviation: GINA, Global Initiative for Asthma.
  3. aIn the previous 7 days.
  4. bIn the previous 12 months.